Alerts will be sent to your verified email
Verify EmailHESTERBIO
Hester Biosciences
|
Venkys India
|
NGL Fine-Chem
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
1.28 % | n/a | 0.94 % |
Financials
|
|||
5 yr Average ROE
|
15.53 % | 11.87 % | 20.08 % |
5yr average Equity Multiplier
|
1.99 | 1.68 | 1.43 |
5yr Average Asset Turnover Ratio
|
0.48 | 2.02 | 1.08 |
5yr Avg Net Profit Margin
|
16.41 % | 3.78 % | 12.69 % |
Price to Book
|
9.35 | 1.97 | 6.23 |
P/E
|
144.41 | 34.1 | 39.59 |
5yr Avg Cash Conversion Cycle
|
87.91 Days | 28.0 Days | 67.77 Days |
Inventory Days
|
105.88 Days | 32.46 Days | 51.05 Days |
Days Receivable
|
91.87 Days | 55.81 Days | 85.22 Days |
Days Payable
|
142.4 Days | 46.67 Days | 73.98 Days |
5yr Average Interest Coverage Ratio
|
8.85 | 8.29 | 21.07 |
5yr Avg ROCE
|
15.9 % | 18.02 % | 27.12 % |
5yr Avg Operating Profit Margin
|
33.25 % | 7.01 % | 22.47 % |
5 yr average Debt to Equity
|
0.68 | 0.22 | 0.2 |
5yr CAGR Net Profit
|
-8.52 % | 42.42 % | 0.28 % |
5yr Average Return on Assets
|
8.15 % | 7.28 % | 14.23 % |
Shareholdings
|
|||
Promoter Holding
|
53.73 % | 56.11 % | 72.74 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -1.07 % |
Change in Mutual Fund Holding (3 Yrs)
|
-0.4 % | 0.04 % | 0.0 |
Hester Biosciences
|
Venkys India
|
NGL Fine-Chem
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Capex
|
Capex
|
-
|
-
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|